Pheophorbide A from Solanum diflorum Interferes with NF-κB Activation

Abstract

Continuing our search for biogenic NF-κB inhibitors we investigated Solanum diflorum, used by the Istmo Sierra Zapotec Indians of Mexico in the treatment of inflammatory skin conditions. It became obvious very early that the active substance seems to be a degradation product of chlorophyll. Pheophorbide A was identified as one of the key compounds responsible for the NF-κB inhibitory activity. The compound interferes with NF-κB activation, was cytotoxic if exposed to light, but devoid of any cytotoxic activity in the dark.

References

• 1 Frei B, Sticher O, Heinrich M. Medical ethnobotany of the Zapotecs of the Isthmus-Sierra (Oaxaca, Mexico).  Journal of Ethnopahrmacology. 1998;  62 149-65
• 2 Frei B, Heinrich M, Bork P M, Herrmann D, Jaki B, Kato T, Kuhnt M, Schmitt J, Schühly W, Volken C, Sticher O. Multiple screening of medicinal plants from Oaxaca, Mexico.  Phytomedicine. 1998;  5 177-86
• 3 Bork P M, Bacher S, Schmitz M L, Kaspers U, Heinrich M. Hypericin as an non-anti-oxidant inhibitor of NF-κB.  Planta Medica. 1999;  65 297-300
• 4 Bork P M, Schmitz M L, Kuhnt M, Escher C, Heinrich M. Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor κB (NF-κB).  FEBS Letters. 1997;  402 85-90
• 5 Bork P M. Screening mexikanischer Arzneipflanzen auf Inhibition der NF-κB-Aktivierung und Isolierung wirksamer Inhaltsstoffe aus Tithonia diversifolia und Solanum diflorum. Dissertation. Univ. Freiburg
• 6 Roeder B, Naaether D, Lewald T, Braune M, Nowack C, Freyer W. Photophysical properties and photodynamic activity in vivo of some tetrapyroles.  Biophysical Chemistry. 1990;  35 303-12
• 7 Schwikkard S L, Mulholland A D, Hutchings A. Pheophytins from Tupara fischeri .  Phytochemistry. 1998;  49 2391-4
• 8 Riehmann K, Behnke B, Schulze-Osthoff K. Plant extracts from stinging nettle (Urtica dioica), an antirheumatic remedy, inhibit the pro-inflammatory transcription factor NF-κB.  FEBS Letters. 1999;  442 89-94
• 9 Hänsel R, Keller K, Rimpler H, Schneider G. Hagers Handbuch der Pharmazeutischen Praxis. Drogen. 3 Bände. Heidelberg; Springer Verlag 1992 - 1994
• 10 Sharman W, Allen C M, Lier van J E. Photodynamic therapeutics.  Drug Development Today. 1999;  4 507-517